Abstract
Purpose
The aim of the study was to compare the performance of two different COMPlog computerised, single letter scoring, visual acuity (VA) measurements against gold standard Early Treatment Diabetic Retinopathy Study (ETDRS) chart measurements in patients with age-related macular degeneration (AMD). One computerised algorithm presented five and the other presented three letters per line; both computerised algorithms utilised half, rather than the full-letter width spacing standard on ETDRS charts that might induce crowding, fixation problems, increased test–retest variability (TRV), and bias.
Methods
Fifty patients with AMD (mean age 83 years) underwent timed test and retest VA measurements using ETDRS charts and COMPlog five (C5) and three (C3) letters per line computerised VA measurement algorithms. All tests utilised single-letter scoring methodology. Bland and Altman methods were employed. Performance was measured in terms of bias, TRV, and test time.
Results
The C5 and C3 scores showed no bias compared with the ETDRS chart measurements. C5 measurements had equal TRV to the ETDRS chart (±0.13 logMAR) with similar median test times (105 and 96 s, respectively). C3 measurements were slightly more variable (TRV ±0.17 logMAR), but 30 s quicker than ETDRS chart measurements.
Conclusions
The closer letter spacing employed in COMPlog testing algorithms appears to have no adverse effect on VA measurements compared with the gold standard ETDRS chart in patients with AMD. The three letter per line testing algorithm facilitates faster testing but with a two letter increase in TRV.
Similar content being viewed by others
Log in or create a free account to read this content
Gain free access to this article, as well as selected content from this journal and more on nature.com
or
References
Lim LS, Mitchell P, Seddon JM, Holz FG, Wong TY . Age-related macular degeneration. Lancet 2012; 379 (9827): 1728–1738.
Ambati J, Fowler BJ . Mechanisms of age-related macular degeneration. Neuron 2012; 75 (1): 26–39.
Colquitt JL, Jones J, Tan SC, Takeda A, Clegg AJ, Price A . Ranibizumab and pegaptanib for the treatment of age-related macular degeneration: a systematic review and economic evaluation. Health Technol Assess 2008; 12 (16): iii–iv, ix–201.
Lalwani GA, Rosenfeld PJ, Fung AE, Dubovy SR, Michels S, Feuer W et al. A variable-dosing regimen with intravitreal ranibizumab for neovascular age-related macular degeneration: year 2 of the PrONTO Study. Am J Ophthalmol 2009; 148 (1): 43–58.e41.
Chew EY, Lindblad AS, Clemons T, Age-Related Eye Disease Study Research G. Summary results and recommendations from the age-related eye disease study. Arch Ophthalmol 2009; 127 (12): 1678–1679.
Laidlaw DA, Abbott A, Rosser DA . Development of a clinically feasible logMAR alternative to the Snellen chart: performance of the "compact reduced logMAR" visual acuity chart in amblyopic children. Br J Ophthalmol 2003; 87 (10): 1232–1234.
Noushad B, Thomas J, Amin SV . Reliability of a modified logMAR distant visual acuity chart for routine clinical use. Oman J Ophthalmol 2012; 5 (2): 87–90.
Carkeet A . Modeling logMAR visual acuity scores: effects of termination rules and alternative forced-choice options. Optom Vis Sci 2001; 78 (7): 529–538.
Arditi A, Cagenello R . On the statistical reliability of letter-chart visual acuity measurements. Invest Ophthalmol Vis Sci 1993; 34 (1): 120–129.
Camparini M, Cassinari P, Ferrigno L, Macaluso C . ETDRS-fast: implementing psychophysical adaptive methods to standardized visual acuity measurement with ETDRS charts. Invest Ophthalmol Vis Sci 2001; 42 (6): 1226–1231.
Rosser DA, Laidlaw DA, Murdoch IE . The development of a "reduced logMAR" visual acuity chart for use in routine clinical practice. Br J Ophthalmol 2001; 85 (4): 432–436.
Hussain B, Saleh GM, Sivaprasad S, Hammond CJ . Changing from Snellen to LogMAR: debate or delay? Clin Experiment Ophthalmol 2006; 34 (1): 6–8.
Laidlaw DA, Tailor V, Shah N, Atamian S, Harcourt C . Validation of a computerised logMAR visual acuity measurement system (COMPlog): comparison with ETDRS and the electronic ETDRS testing algorithm in adults and amblyopic children. Br J Ophthalmol 2008; 92 (2): 241–244.
Beck RW, Moke PS, Turpin AH, Ferris FL, SanGiovanni JP, Johnson CA et al. A computerized method of visual acuity testing: adaptation of the early treatment of diabetic retinopathy study testing protocol. Am J Ophthalmol 2003; 135 (2): 194–205.
Cotter SA, Chu RH, Chandler DL, Beck RW, Holmes JM, Rice ML et al. Reliability of the electronic early treatment diabetic retinopathy study testing protocol in children 7 to <13 years old. Am J Ophthalmol 2003; 136 (4): 655–661.
Sloan LL RW, Altman A . Comparison of three types of test target for the measurement of visual acuity. Q Rev Opthalmol 1952; 8: 4–16.
Shah N, Laidlaw DA, Brown G, Robson C . Effect of letter separation on computerised visual acuity measurements: comparison with the gold standard Early Treatment Diabetic Retinopathy Study (ETDRS) chart. Ophthalmic Physiol Opt 2010; 30 (2): 200–203.
Cacho I, Dickinson CM, Reeves BC, Harper RA . Visual acuity and fixation characteristics in age-related macular degeneration. Optom Vis Sci 2007; 84 (6): 487–495.
Crossland MD, Engel SA, Legge GE . The preferred retinal locus in macular disease: toward a consensus definition. Retina 2011; 31 (10): 2109–2114.
Cheung SH, Legge GE . Functional and cortical adaptations to central vision loss. Vis Neurosci 2005; 22 (2): 187–201.
Patel PJ, Chen FK, Rubin GS, Tufail A . Intersession repeatability of visual acuity scores in age-related macular degeneration. Invest Ophthalmol Vis Sci 2008; 49 (10): 4347–4352.
Shah N, Laidlaw DA, Rashid S, Hysi P . Validation of printed and computerised crowded Kay picture logMAR tests against gold standard ETDRS acuity test chart measurements in adult and amblyopic paediatric subjects. Eye (Lond) 2012; 26 (4): 593–600.
Bland JM, Altman DG . Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1986; 1 (8476): 307–310.
Ehrmann K, Fedtke C, Radic A . Assessment of computer generated vision charts. Cont Lens Anterior Eye 2009; 32 (3): 133–140.
Siderov J, Tiu AL . Variability of measurements of visual acuity in a large eye clinic. Acta ophthalmologica Scandinavica 1999; 77 (6): 673–676.
Lovie-Kitchin JE . Validity and reliability of visual acuity measurements. Ophthalmic Physiol Opt 1988; 8 (4): 363–370.
Reeves BC, Wood JM, Hill AR . Vistech VCTS 6500 charts—within- and between-session reliability. Optom Vis Sci 1991; 68 (9): 728–737.
Elliott DB, Sheridan M . The use of accurate visual acuity measurements in clinical anti-cataract formulation trials. Optom Vis Sci 1988; 8 (4): 397–401.
Cousens SN, Rosser DA, Murdoch IE, Laidlaw DA . A simple model to predict the sensitivity to change of visual acuity measurements. Optom Vis Sci 2004; 81 (9): 673–677.
Williams MA, Moutray TN, Jackson AJ . Uniformity of visual acuity measures in published studies. Invest Ophthalmol Vis Sci 2008; 49 (10): 4321–4327.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
DAHL and colleagues, and St Thomas’ Foundation NHS Trust have proprietary interests in the COMPlog visual acuity measurement system. The remaining authors declare no conflict of interest.
Rights and permissions
About this article
Cite this article
Bokinni, Y., Shah, N., Maguire, O. et al. Performance of a computerised visual acuity measurement device in subjects with age-related macular degeneration: comparison with gold standard ETDRS chart measurements. Eye 29, 1085–1091 (2015). https://doi.org/10.1038/eye.2015.94
Received:
Accepted:
Published:
Issue date:
DOI: https://doi.org/10.1038/eye.2015.94
This article is cited by
-
Effect of different screen brightness and devices on online visual acuity test
Graefe's Archive for Clinical and Experimental Ophthalmology (2024)
-
Vitrectomy, subretinal Tissue plasminogen activator and Intravitreal Gas for submacular haemorrhage secondary to Exudative Age-Related macular degeneration (TIGER): study protocol for a phase 3, pan-European, two-group, non-commercial, active-control, observer-masked, superiority, randomised controlled surgical trial
Trials (2022)
-
Differences in macular vessel density in the superficial plexus across cognitive impairment: the NORFACE cohort
Scientific Reports (2022)
-
Association between retinal thickness and β-amyloid brain accumulation in individuals with subjective cognitive decline: Fundació ACE Healthy Brain Initiative
Alzheimer's Research & Therapy (2020)
-
Visual impairment in aging and cognitive decline: experience in a Memory Clinic
Scientific Reports (2019)
